Certified by Founder Lodge
eGenesis, Inc.
United States - Cambridge, MA
START UP
1 Disclosed Funding Rounds $191,000,000
0 Participating Investments
-
Founded date
2015
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
eGenesis is revolutionizing the field of transplantation with an unparalleled, multiplexed gene editing platform for the development of human-compatible organs, tissues and cells. Harnessing
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| September, 04 ,2024 | Series B | $191,000,000 |
Lux Capital
ARCH Venture Partners
Farallon Capital Management
Leaps by Bayer
Alta Partners
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Alchemyca Biotech | $2,500,000 | (Nov 22, 2024)
Shinami | $5,645,000 | (Nov 22, 2024)
Iontra Inc | $45,000,000 | (Nov 22, 2024)
Clean Skin Club | $32,000,000 | (Nov 22, 2024)
Lighthouse (UK) | $370,000,000 | (Nov 22, 2024)
